Jay H Traverse, MD | |
800 E 28th St, Minneapolis, MN 55407-3723 | |
(612) 775-3030 | |
Not Available |
Full Name | Jay H Traverse |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 35 Years |
Location | 800 E 28th St, Minneapolis, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306807458 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 34287 (Minnesota) | Secondary |
207RI0011X | Internal Medicine - Interventional Cardiology | 34287 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Glencoe Regional Health Services | Glencoe, MN | Hospital |
New Ulm Medical Center | New ulm, MN | Hospital |
Ridgeview Medical Center | Waconia, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allina Health System | 4587573613 | 3071 |
News Archive
Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Offering "modest" financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.
› Verified 1 days ago
Entity Name | Glencoe Regional Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508885633 PECOS PAC ID: 1759292980 Enrollment ID: O20031119000252 |
News Archive
Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Offering "modest" financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.
› Verified 1 days ago
Entity Name | Allina Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Offering "modest" financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.
› Verified 1 days ago
Entity Name | Glencoe Regional Health Services |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1508885633 PECOS PAC ID: 1759292980 Enrollment ID: O20060504000699 |
News Archive
Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Offering "modest" financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jay H Traverse, MD 920 E 28th St Ste 300, Minneapolis, MN 55407-1195 Ph: (612) 863-3900 | Jay H Traverse, MD 800 E 28th St, Minneapolis, MN 55407-3723 Ph: (612) 775-3030 |
News Archive
Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Offering "modest" financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.
› Verified 1 days ago
Pascal Frino, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |